1.
|
|
2.
|
5 p, 420.5 KB |
Evolocumab has no effects on heart failure with reduced ejection fraction injury biomarkers : The EVO-HF trial
/
Bayés-Genís, Antoni (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Lupón, Josep (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Revuelta-López, Elena (Institut Germans Trias i Pujol) ;
Llibre, Cinta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Gastelurrutia, Paloma (Institut Germans Trias i Pujol) ;
Domingo, Mar (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Cediel, Germán (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Codina, Pau (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Santiago Vacas, Evelyn (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rangel-Sousa, Diego (Hospital Universitario Virgen del Rocío (Andalusia)) ;
Fernández-Cisnal, Agustín (Fundación Investigación Clínico de Valencia-Instituto de Investigación Sanitaria) ;
Miñana, Gema (Universitat de València. Departament de Medicina) ;
Mollar, Anna (Fundación Investigación Clínico de Valencia-Instituto de Investigación Sanitaria) ;
Núñez, Julio (Universitat de València. Departament de Medicina)
Aim: Patients with heart failure with reduced ejection fraction (HFrEF) have not been shown to benefit from statins. We hypothesized that, by limiting disease progression in stable HFrEF of ischaemic etiology, the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor evolocumab could reduce circulating troponin levels, a surrogate biomarker of myocyte injury and atherosclerosis progression. [...]
2023 - 10.1002/ejhf.2932
European Journal of Heart Failure, Vol. 25 Núm. 8 (august 2023) , p. 1439-1443
|
|
3.
|
8 p, 275.5 KB |
Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond
/
Aimo, Alberto (Fondazione Toscana Gabriele Monasterio) ;
Spitaleri, Giosafat (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Nieri, Dario (Pisa University Hospital) ;
Tavanti, Laura Maria (Pisa University Hospital) ;
Meschi, Claudia (University of Pisa) ;
Panichella, Giorgia (Scuola Superiore Sant'Anna) ;
Lupón, Josep (Instituto de Salud Carlos III) ;
Pistelli, Francesco (Pisa University Hospital) ;
Carrozzi, Laura (University of Pisa) ;
Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Emdin, Michele (Fondazione Toscana Gabriele Monasterio) ;
Universitat Autònoma de Barcelona
Pirfenidone (PFD) slows the progression of idiopathic pulmonary fibrosis (IPF) by inhibiting the exaggerated fibrotic response and possibly through additional mechanisms, such as anti-inflammatory effects. [...]
2022 - 10.15420/cfr.2021.30
Cardiac Failure Review, Vol. 8 (april 2022)
|
|
4.
|
21 p, 1.6 MB |
A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
/
de la Fuente, Ana (Clínica Universidad de Navarra) ;
Santisteban, Marta (Clínica Universidad de Navarra) ;
Lupón, Josep (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Aramendía, José Manuel (Clínica Universidad de Navarra) ;
Díaz, Agnes (Clínica Universidad de Navarra) ;
Santaballa, Ana (Instituto de Investigación Sanitaria La Fe) ;
Hernándiz, Amparo (Instituto de Investigación Sanitaria La Fe) ;
Sepúlveda, Pilar (Instituto de Investigación Sanitaria La Fe) ;
Cediel, Germán (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
López, Begoña (Clínica Universidad de Navarra) ;
Picazo, José María López (Clínica Universidad de Navarra) ;
Mazo, Manuel M. (Clínica Universidad de Navarra) ;
Rábago, Gregorio (Clínica Universidad de Navarra) ;
Gavira, Juan José (Clínica Universidad de Navarra) ;
García-Bolao, Ignacio (Clínica Universidad de Navarra) ;
Díez, Javier (Clínica Universidad de Navarra) ;
González, Arantxa (Clínica Universidad de Navarra) ;
Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ravassa, Susana (Clínica Universidad de Navarra) ;
Universitat Autònoma de Barcelona
Left ventricular dysfunction (LVD) induced by anthracycline-based cancer chemotherapy (ACC) is becoming an urgent healthcare concern. Myocardial fibrosis (MF) may contribute to LVD after ACC. We show that elevated circulating levels of procollagen type I C-terminal propeptide (PICP, biomarker of MF) are associated with early subclinical LVD and predict later development of cardiotoxicity in patients treated with ACC. [...]
2022 - 10.3390/cancers14122941
Cancers, Vol. 14 (june 2022)
|
|
5.
|
11 p, 850.5 KB |
Non-STEMI vs. STEMI Cardiogenic Shock : Clinical Profile and Long-Term Outcomes
/
Martínez, María José (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rueda, Ferran (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Labata, Carlos (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Oliveras, Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Montero, Santiago (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ferrer Vinardel, Marc (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
El Ouaddi, Nabil (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Serra, Jordi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Lupón, Josep (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Garcia Garcia, Cosme (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona
Cardiogenic shock (CS) is a severe complication of acute myocardial infarction (AMI). In AMI-CS, the ST segment deviation on ECG may be elevated (STEMI-CS) or non-elevated (NSTEMI-CS), which may influence prognosis. [...]
2022 - 10.3390/jcm11123558
Journal of clinical medicine, Vol. 11 (june 2022)
|
|
6.
|
13 p, 3.5 MB |
Electrophysiological effects of adipose graft transposition procedure (AGTP) on the post-myocardial infarction scar : A multimodal characterization of arrhythmogenic substrate
/
Adeliño, Raquel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Martínez-Falguera, Daina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Curiel, Carolina (Boston Scientific Department. Barcelona Delegation) ;
Teis, Albert (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Marsal, Roger (Boston Scientific Department. Barcelona Delegation) ;
Rodríguez-Leor, Oriol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Prat-Vidal, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Fadeuilhe, Edgar (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Aranyó, Júlia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Revuelta-López, Elena (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Sarrias, Axel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Bazán, Víctor (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Andrés-Cordón, Joan Francesc (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Roura, Santiago (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Villuendas-Sabaté, Roger (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Lupón, Josep (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Gálvez-Montón, Carolina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Bisbal, Felipe (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona
To assess the arrhythmic safety profile of the adipose graft transposition procedure (AGTP) and its electrophysiological effects on post-myocardial infarction (MI) scar. Myocardial repair is a promising treatment for patients with MI. [...]
2022 - 10.3389/fcvm.2022.983001
Frontiers in Cardiovascular Medicine, Vol. 9 (september 2022)
|
|
7.
|
11 p, 1.8 MB |
Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension
/
Codina, Pau (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Domingo, Mar (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Barceló, Elena (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Gastelurrutia, Paloma (Institut d'Investigació Biomèdica de Bellvitge) ;
Casquete, Daniel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Vila, Joan (Hospital del Mar (Barcelona, Catalunya)) ;
Abdul-Jawad Altisent, Omar (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Spitaleri, Giosafat (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Cediel, Germán (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Santiago Vacas, Evelyn (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Zamora, Elisabet (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ruiz-Cueto, María (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Santesmases, Javier (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
De la Espriella, Rafael (Universitat de València) ;
Pascual-Figal, Domingo A. (Centro Nacional de Investigaciones cardiovasculares (CNIC)) ;
Núñez, Julio (Universitat de València) ;
Lupón, Josep (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona
Prior studies have not fully characterized the haemodynamic effects of the angiotensin receptor-neprilysin inhibitor (ARNI) sacubitril/valsartan in heart failure with preserved ejection fraction and pulmonary hypertension (HFpEF-PH). [...]
2022 - 10.1002/ehf2.13952
ESC Heart Failure, Vol. 9 (may 2022) , p. 2170-2180
|
|
8.
|
10 p, 461.9 KB |
Quality of life in patients with heart failure and improved ejection fraction : one-year changes and prognosis
/
Zamora, Elisabet (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
González Fernández, Beatriz (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Lupón, Josep (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Borrellas, Andrea (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Domingo, Mar (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Santiago Vacas, Evelyn (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Cediel, Germán (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Codina, Pau (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rivas, Carmen (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Pulido, Ana (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Crespo, Eva (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Velayos, Patricia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Díaz, Violeta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona
The criteria for patients with heart failure (HF) and improved ejection fraction (HFimpEF) are a baseline left ventricular ejection fraction (LVEF) ≤40%, a ≥10-point increase from baseline LVEF, and a second LVEF measurement >40%. [...]
2022 - 10.1002/ehf2.14098
ESC Heart Failure, Vol. 9 (august 2022) , p. 3804-3813
|
|
9.
|
14 p, 535.9 KB |
Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy
/
Díez-López, Carles (Universitat de Barcelona. Departament de Medicina) ;
Salazar-Mendiguchía, Joel (Hospital Universitari de Bellvitge. Servei de Cardiologia) ;
García-Romero, Elena (Institut d'Investigació Biomèdica de Bellvitge) ;
Fuentes, Lara (Institut d'Investigació Biomèdica de Bellvitge) ;
Lupón, Josep (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Bayés-Genís, Antoni (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Manito, Nicolás (Hospital Universitari de Bellvitge. Servei de Cardiologia) ;
de Antonio Ferrer, Marta (Institut d'Investigació Biomèdica Sant Pau) ;
Moliner, Pedro (Programa d'insuficiència cardíaca comunitària. Hospital Universitari de Bellvitge. Servei de Cardiologia) ;
Zamora, Elisabet (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Catalá-Ruiz, Pablo (Institut d'Investigació Biomèdica de Bellvitge) ;
Cainzos-Achirica, Miguel (RTI Health Solutions. Pharmacoepidemiology and Risk Management) ;
Comín-Colet, Josep (Programa d'insuficiència cardíaca comunitària. Hospital Universitari de Bellvitge. Servei de Cardiologia) ;
González-Costello, José (Universitat de Barcelona. Departament de Medicina)
Aims: Non-ischaemic dilated cardiomyopathy (NIDCM) is characterized by left ventricular (LV) chamber enlargement and systolic dysfunction in the absence of coronary artery disease. Left ventricular reverse remodelling (LVRR) is the ability of a dilated ventricle to restore its normal size, shape and function. [...]
2022 - 10.3390/jcdd9010020
Journal of Cardiovascular Development and Disease, Vol. 9 Núm. 1 (january 2022) , p. 20
|
|
10.
|
13 p, 983.7 KB |
Fatty Acid Binding Proteins 3 and 4 Predict Both All-Cause and Cardiovascular Mortality in Subjects with Chronic Heart Failure and Type 2 Diabetes Mellitus
/
Rodríguez-Calvo, Ricardo (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ;
Granado-Casas, Minerva (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
Pérez-Montes de Oca, Alejandra (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Julián, María Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Domingo, Mar (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Codina, Pau (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Santiago Vacas, Evelyn (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Cediel, Germán (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Julve i Gil, Josep (Institut d'Investigació Biomèdica Sant Pau) ;
Rossell, Joana (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ;
Masana, Lluís (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ;
Mauricio Puente, Dídac (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Lupón, Josep (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Bayés-Genís, Antoni (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Alonso Pedrol, Núria (Universitat Autònoma de Barcelona. Departament de Medicina)
Subjects with type 2 diabetes mellitus (T2D) are at increased risk for heart failure (HF). The cardiac-specific (FABP3) and adipose-tissue-specific (FABP4) types of the fatty acid binding proteins have been associated with both all-cause and cardiovascular (CV) mortality. [...]
2023 - 10.3390/antiox12030645
Antioxidants, Vol. 12 (march 2023)
|
|